Evolution of a 1,3Galactosyltransferase and of the a- Gal epitope In a-Gal and Anti-Gal: a-1,3-galactosyltransferase, a- Gal epitopes, and the natural anti-Gal antibody Edited by, pp.1-18 ,
Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells, J Biol Chem, vol.263, pp.17755-17762, 1988. ,
Altered T cell surface glycosylation in HIV-1 infection results in increased susceptibility to galectin-1-induced cell death, Glycobiology, vol.13, issue.12, pp.909-918, 2003. ,
DOI : 10.1093/glycob/cwg110
Anti-Gal: a-1,3-galactosyltransferase, a-Gal epitopes, and the natural anti-Gal antibody, 1999. ,
or Epithelial Ovarian Cancer. M.D. Anderson Cancer Center, Houston, Texas, Human Gene Therapy, vol.9, issue.12, pp.1775-1798, 1998. ,
DOI : 10.1089/hum.1998.9.12-1775
Xenotransplantation - state of the art - Update 1999, Frontiers in Bioscience, vol.4, issue.1-3, pp.416-432, 1999. ,
DOI : 10.2741/Buhler
Sensitization of Human Cells to Lysis by Human Complement as an Approach for Cancer Gene Therapy, Adv Exp Med Biol, vol.451, pp.359-363, 1998. ,
DOI : 10.1007/978-1-4615-5357-1_56
Eliciting hyperacute xenograft response to treat human cancer: alpha(1,3) galactosyltransferase gene therapy, Anticancer Res, vol.18, pp.2301-2308, 1998. ,
Immunity to the alpha(1,3)galactosyl epitope provides protection in mice challenged with colon cancer cells expressing alpha(1,3)galacto- syl-transferase: a novel suicide gene for cancer gene therapy, Cancer Res, vol.63, pp.987-993, 2003. ,
Decrease of human pancreatic cancer cell tumorigenicity by ?1,3galactosyltransferase gene transfer, International Journal of Cancer, vol.116, issue.6, pp.910-918, 2003. ,
DOI : 10.1002/ijc.11470
Targeting gene therapy to cancer: a review, Oncol Res, vol.9, pp.313-325, 1997. ,
Use of transcriptional regulatory elements of the MUC1 and ERBB2 genes to drive tumour-selective expression of a prodrug activating enzyme, Gene Therapy, vol.4, issue.10, pp.1045-1052, 1997. ,
DOI : 10.1038/sj.gt.3300510
Therapies directed at vascular endothelial growth factor, Expert Opinion on Investigational Drugs, vol.295, issue.1, pp.1715-1736, 2002. ,
DOI : 10.1021/jm990345w
Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene, Science, vol.235, issue.4785, pp.177-182, 1987. ,
DOI : 10.1126/science.3798106
Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms, Embo J, vol.6, pp.605-610, 1987. ,
Biologic and therapeutic role of HER2 in cancer, Oncogene, vol.22, issue.42, pp.6570-6578, 2003. ,
DOI : 10.1038/sj.onc.1206779
HER2/Neu: mechanisms of dimerization/oligomerization, Oncogene, vol.19, issue.53, pp.6093-6101, 2000. ,
DOI : 10.1038/sj.onc.1203967
Expression of the c-ErbB-2/HER2 proto-oncogene in normal hematopoietic cells, Journal of Leukocyte Biology, vol.74, issue.4, pp.593-601, 2003. ,
DOI : 10.1189/jlb.0203068
Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer, Science, vol.244, issue.4905, pp.707-712, 1989. ,
DOI : 10.1126/science.2470152
Detection of HER-2/neu oncogene amplification in flow cytometry-sorted breast ductal cells by competitive polymerase chain reaction, Cancer, vol.84, issue.11, pp.2771-2778, 1994. ,
DOI : 10.1002/1097-0142(19940601)73:11<2771::AID-CNCR2820731120>3.0.CO;2-K
Quantification of HER2/neu gene amplification by competitive pcr using fluorescent melting curve analysis, Clin Chem, vol.47, pp.844-851, 2001. ,
Transcriptional targeting of the HER-2/ neu oncogene, Drugs Today, vol.36, pp.835-843, 2000. ,
Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene, Science, vol.230, issue.4730, pp.1132-1139, 1985. ,
DOI : 10.1126/science.2999974
The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors, Proceedings of the National Academy of Sciences, vol.95, issue.12, pp.4995-5000, 1999. ,
DOI : 10.1073/pnas.95.12.6809
The ErbB receptors and their role in cancer progression, Experimental Cell Research, vol.284, issue.1, pp.99-110, 2003. ,
DOI : 10.1016/S0014-4827(02)00099-X
Identification of a minimal c-erbB-2 promoter region that mediates preferential expression of a linked foreign gene in human breast cancer cells, International Journal of Oncology, vol.20, pp.607-610, 2002. ,
DOI : 10.3892/ijo.20.3.607
Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells., Proceedings of the National Academy of Sciences, vol.83, issue.10, pp.3194-3198, 1986. ,
DOI : 10.1073/pnas.83.10.3194
Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line, Journal of Experimental Medicine, vol.180, issue.5, pp.1609-1617, 1994. ,
DOI : 10.1084/jem.180.5.1609
Cloning and Expression of cDNA for a Human Gal(beta1-3)GalNAc alpha2,3-Sialyltransferase from the CEM T-Cell Line, European Journal of Biochemistry, vol.69, issue.2, pp.558-566, 1997. ,
DOI : 10.1074/jbc.270.36.20987
An intracellular anti-erbB-2 single-chain antibody is specifically cytotoxic to human breast carcinoma cells overexpressing erbB-2, Gene Therapy, vol.4, issue.4, pp.317-322, 1997. ,
DOI : 10.1038/sj.gt.3300372
Soluble HER-2/neu neutralizes biologic effects of anti-HER-2/neu antibody on breast cancer cellsin vitro, International Journal of Cancer, vol.7, issue.6, pp.875-879, 1997. ,
DOI : 10.1002/(SICI)1097-0215(19971210)73:6<875::AID-IJC19>3.0.CO;2-3
Overexpression of HER2 modulates bcl-2, bcl-XL, and tamoxifeninduced apoptosis in human MCF-7 breast cancer cells, Clin Cancer Res, vol.2, pp.1215-1219, 1996. ,
Inhibition of HER2/neu (erbB-2) and mitogen-activated protein kinases enhances tamoxifen action against HER2-overexpressing, tamoxifen-resistant breast cancer cells, Cancer Res, vol.60, pp.5887-5894, 2000. ,
Cell type-dependent and -independent control of HER-2/neu translation, The International Journal of Biochemistry & Cell Biology, vol.31, issue.1, pp.201-213, 1999. ,
DOI : 10.1016/S1357-2725(98)00068-5
Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5, Journal of General Virology, vol.36, issue.1, pp.59-74, 1977. ,
DOI : 10.1099/0022-1317-36-1-59
Expression of antisense E1A in 293 cells results in altered cell morphologies and cessation of proliferation, Oncogene, vol.8, pp.257-265, 1993. ,
Potential Role of Microsomal Prostaglandin E Synthase-1 in Tumorigenesis, Journal of Biological Chemistry, vol.278, issue.21, pp.19396-19405, 2003. ,
DOI : 10.1074/jbc.M213290200
Prodrug-activating systems in suicide gene therapy, Journal of Clinical Investigation, vol.105, issue.9, pp.1161-1167, 2000. ,
DOI : 10.1172/JCI10001
A unique natural human IgG antibody with anti-alpha-galactosyl specificity, Journal of Experimental Medicine, vol.160, issue.5, pp.1519-1531, 1984. ,
DOI : 10.1084/jem.160.5.1519
Identification of carbohydrate structures that bind human antiporcine antibodies: implications for discordant xenografting in humans, Transplant Proc, vol.24, pp.559-562, 1992. ,
3-Galactosyltrans- ferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies, Transplant Proc, vol.1, issue.28, pp.556-557, 1996. ,
Naturally acquired anti-alphaGal antibodies in a murine allograft model similar to delayed xenograft rejection, Xenotransplantation, vol.62, issue.1, pp.42-47, 2000. ,
DOI : 10.1016/S1050-1738(98)00021-8
Xenoantigen, an alphaGal epitope-expression construct driven by the hTERT-promoter, specifically kills human pancreatic cancer cell line, Cancer Cell International, vol.2, issue.1, pp.14-20, 2002. ,
DOI : 10.1186/1475-2867-2-14
Inhibitors of HER2/neu (erbB-2) signal transduction, Seminars in Oncology, vol.28, pp.30-35, 2001. ,
DOI : 10.1016/S0093-7754(01)90106-X
Update on HER-2 as a target for cancer therapy: The ERBB2 promoter and its exploitation for cancer treatment, Breast Cancer Research, vol.19, issue.6, pp.395-398, 2001. ,
DOI : 10.1093/emboj/19.9.2024
Ets regulation of the erbB2 promoter, Oncogene, vol.19, issue.55, pp.6490-6502, 2000. ,
DOI : 10.1038/sj.onc.1204041
The ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis, Nat Med, vol.6, pp.189-195, 2000. ,
Transcriptional repression of the neu protooncogene by the adenovirus 5 E1A gene products., Proceedings of the National Academy of Sciences, vol.87, issue.12, pp.4499-4503, 1990. ,
DOI : 10.1073/pnas.87.12.4499
The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer, Oncogene, vol.14, issue.5, pp.561-568, 1997. ,
DOI : 10.1038/sj.onc.1200861
Overexpression of ErbB2 in cancer and ErbB2-targeting strategies, Oncogene, vol.19, issue.53, pp.6115-6121, 2000. ,
DOI : 10.1038/sj.onc.1203972
Efficient engraftment of human primary breast cancer transplants in nonconditioned NOD/Scid mice, International Journal of Cancer, vol.90, issue.4, pp.444-453, 2003. ,
DOI : 10.1002/ijc.11125
Oocyte Gal??1,3Gal Epitopes Implicated in Sperm Adhesion to the Zona Pellucida Glycoprotein ZP3 Are Not Required for Fertilization in the Mouse, Journal of Biological Chemistry, vol.270, issue.37, pp.21437-21440, 1995. ,
DOI : 10.1074/jbc.270.37.21437
THE ??-1,3-GALACTOSYLTRANSFERASE KNOCKOUT MOUSE, Transplantation, vol.61, issue.1, pp.13-19, 1996. ,
DOI : 10.1097/00007890-199601150-00004